Your session is about to expire
Triazolam vs Ambien
Introduction
For individuals struggling with insomnia or other sleep disorders, certain medications that affect the central nervous system can assist in inducing sleep and managing nocturnal disturbances. Triazolam and Ambien (Zolpidem) are two such drugs often prescribed for these conditions. Both impact receptors within the brain tied to sedation, yet each has a unique mechanism of action.
Triazolam is a short-acting benzodiazepine known for its rapid onset of effects. It enhances the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter that decreases neuronal excitability throughout the nervous system.
On the other hand, Ambien falls under non-benzodiazepines, also known as 'Z-drugs'. Although it acts on GABA receptors similarly to triazolam, it primarily targets GABA-A receptor complexes at particular subunit sites which makes its effect more specific thus causing fewer side effects compared to benzodiazepines.
Triazolam vs Ambien Side By Side
| Attribute | Halcion | Ambien |
|---|---|---|
| Brand Name | Halcion | Ambien |
| Contraindications | Should not be taken with certain antifungal treatments (such as ketoconazole), certain antibiotics (like erythromycin) or with grapefruit/grapefruit juice. | Similar to Triazolam, should not be taken with certain antifungal treatments, certain antibiotics, or with grapefruit/grapefruit juice. |
| Cost | For the brand name, around $120 for 30 tablets (0.25 mg). For the generic, approximately $15 to $60 for 30 tablets (0.25 mg). | For the brand name, about $190 for 30 tablets (10 mg). For the generic, prices start as low as about $.50/day up to around $3/day. |
| Generic Name | Triazolam | Zolpidem |
| Most Serious Side Effect | Agitation or aggressiveness, signs of an allergic reaction, changes in vision, irregular heart rate or palpitations, shortness of breath, feelings of fainting, low sodium levels, severe nervous system response. | Signs of an allergic reaction, unusual thoughts or behavior, anxiety and depression symptoms, hallucinations or confusion, aggressive and restless behavior, memory issues, problems with speech or vision, chest pain, irregular heartbeats. |
| Severe Drug Interactions | Certain antifungal treatments, certain antibiotics, grapefruit/grapefruit juice. | Certain antifungal treatments, certain antibiotics, grapefruit/grapefruit juice. |
| Typical Dose | 0.125-0.5 mg/day, with a starting dose for older adults usually at 0.125 mg/day. | 5-10 mg/day, taken once nightly immediately before bedtime. For patients over the age of 65 or those with hepatic impairment, a lower dose of 5mg daily is recommended. |
What is Triazolam?
Triazolam (the generic name for Halcion) is a benzodiazepine class drug which was introduced as an alternative to the first wave of sleep medications known as barbiturates. Triazolam was first approved by the FDA in 1982. It works by slowing activity in the brain to allow sleep, and it's commonly prescribed for insomnia or other severe sleeping disorders. Triazolam has a selective influence on GABA neurotransmitters with only minor influences on others, resulting in it having fewer side effects than other sedatives with broader neurological impacts.
On the flip side, Zolpidem (commonly known under its brand name Ambien) is one of non-benzodiazepines, often referred to as 'Z-drugs', developed later with an aim at achieving similar benefits but with less potential for misuse or dependency. It also increases GABA effects in the central nervous system to promote sleep but does so slightly differently than Triazolam, potentially leading to different experiences and side effects between individuals.
What conditions is Triazolam approved to treat?
Triazolam is approved for the short-term treatment of insomnia:
- Specifically, it's used to treat difficulty falling asleep (sleep onset insomnia)
- It can also be utilized in some cases where sleep maintenance (staying asleep) is an issue
- It's not typically recommended for long-term use due to risks of dependency and withdrawal issues
On the other hand, Ambien is also approved for short term treatment of insomnia:
- Primarily targeting difficulties with sleep initiation
- Extended release versions are available that may help with maintaining sleep throughout the night.
How does Triazolam help with these illnesses?
Triazolam is a medication designed to help manage insomnia by increasing the amount of gamma-aminobutyric acid (GABA) in the brain. It accomplishes this by enhancing its effects, allowing for increased sedation and causing users to feel sleepy. GABA is a neurotransmitter that inhibits or slows down brain activity, which plays an important role in relaxation, reducing stress, and promoting sleep. Individuals with insomnia are thought to have relatively lower levels or less effective use of GABA. Therefore, by augmenting GABA's effects, triazolam can limit the negative impacts of insomnia and assist patients in managing their condition and stabilizing their sleep patterns.
What is Ambien?
Ambien is a brand name for zolpidem, which is a sedative-hypnotic medication used to treat insomnia. It acts on the GABA neurotransmitter system in your brain by enhancing its effects and promoting sleep. This action results in the slowing down of brain activity, making it easier for you to fall asleep. Zolpidem was first approved by the FDA in 1992.
As Ambien does not work like benzodiazepines (such as triazolam), it has different interactions with GABA receptors and hence possesses a unique side-effect profile compared to these drugs. Specifically, while both medications can cause drowsiness or dizziness during waking hours if taken improperly, Ambien typically causes less daytime grogginess than benzodiazepines like triazolam might.
Moreover, Ambien doesn't have an impact on certain parts of the body that are affected by benzodiazepines - this means that it's generally less likely to cause muscle relaxation or anti-anxiety effects. However, zolpidem can still be beneficial for those who need assistance with falling asleep but do not necessarily require anxiety relief or muscle relaxation.
What conditions is Ambien approved to treat?
Ambien, known generically as zolpidem, has been accredited by the FDA for the management of:
- Insomnia characterized by difficulties with sleep initiation
- Sleep maintenance disorders (in an extended-release form)
These approvals make Ambien a primary choice for many patients seeking relief from persistent sleep troubles.
How does Ambien help with these illnesses?
Ambien, scientifically known as zolpidem, operates by interacting with the GABA neurotransmitter system in the brain. This interaction slows down neural activity and promotes a calming effect conducive to sleep. Much like GABA itself, Ambien plays an integral part in managing overactivity in the brain that may lead to insomnia. Unlike triazolam, which is a benzodiazepine functioning on numerous receptor sites within this system, Ambien primarily targets a specific subtype of the GABA receptor—known as the GABAA receptor—which is directly associated with sleep regulation. This allows Ambien to promote restful sleep while limiting potential side effects commonly seen with broader-acting medications such as triazolam. Hence it might be prescribed when patients don't respond well or have adverse reactions to benzodiazepines.
How effective are both Triazolam and Ambien?
Triazolam and zolpidem (Ambien) are both effective in treating insomnia, with established histories of success since they were approved by the FDA. Triazolam was first marketed in 1982, followed by Ambien a decade later in 1992. Both drugs work on GABA receptors to enhance its inhibitory effects and induce sleep.
A double-blind clinical trial conducted in 2008 compared triazolam against zolpidem for their effectiveness at inducing and maintaining sleep. The study revealed that both medications exhibited similar efficacy and safety profiles when it comes to managing symptoms of insomnia. Notably, there weren't any significant differences between patients receiving triazolam or those receiving zolpidem across various metrics such as total sleep time or onset of sleep latency.
In a review article from 2017, it was highlighted that triazolam is highly effective as a short-term treatment for insomnia due to its quick onset of action but must be used cautiously because it can potentially cause side effects like daytime sedation or memory impairment if misused. On the other hand, Zolpidem has become one of the most widely prescribed sleeping aids globally due to its efficacy at initiating sleep without major disruption to normal sleep architecture.
Another review published in 2020 indicated that while zolpidem seems more effective than placebo for short-term treatment of insomnia with fewer rebound effects upon discontinuation compared to older hypnotics like benzodiazepines, caution should still be exercised regarding potential adverse events including complex behaviors such as 'sleep-driving'. Nonetheless, given individual biological differences among patients including age-related changes in drug metabolism or co-existing health conditions coupled with unique pharmacology characteristics associated with each drug - either triazolum or zoplidim might be deemed optimal based on patient-specific needs after comprehensive evaluation.
Related trials for triazolam and ambien
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Triazolam typically prescribed?
Oral dosages of Triazolam typically range from 0.125-0.5 mg/day, with most people finding relief from insomnia at the lower end of this spectrum. For older adults, a starting dose is usually 0.125 mg/day to minimize adverse effects. In any case, dosage can be increased after some days if there is no response or improvement in sleep quality but should never exceed 0.5 mg/day due to risk of dependence and severe withdrawal symptoms.
At what dose is Ambien typically prescribed?
Ambien treatment for insomnia typically begins with a dosage of 5-10 mg/day, taken once nightly immediately before bedtime on an empty stomach. The dose can potentially be increased to 12.5 mg per day if the initial lower doses are not effective in inducing sleep after several days. This is generally divided into one single dose due to its function as a sleep aid and should not be exceeded over this amount without consultation from your healthcare provider. For patients over the age of 65 or those with hepatic impairment, it's recommended they start at a lower dose of 5mg daily. It's key that Ambien usage be closely monitored by the prescribing physician for effectiveness and potential side effects.
What are the most common side effects for Triazolam?
Common side effects of Triazolam can include:
- Drowsiness or sleepiness
- Coordination problems
- Lightheadedness
- Nausea
- Vomiting
- Headache
- Nervousness or restlessness
On the other hand, Ambien may cause side effects such as:
- Sleepiness during the day
- Dizziness or lightheadedness
- Diarrhea
- Grogginess or feeling "drugged"
It's important to note that both medications can lead to dependency if used for a long period and should be taken only under medical supervision. Always consult your healthcare provider about potential risks and benefits before starting any medication.
Are there any potential serious side effects for Triazolam?
Triazolam and Ambien are both commonly used as sleep aids, but they may have different side effects. For Triazolam, watch out for the following potential serious symptoms:
- Agitation or aggressiveness
- Signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat
- Changes in vision including blurred vision
- Irregular heart rate or palpitations
- Shortness of breath
- Feelings of fainting
- Low sodium levels - headache, confusion, slurred speech, severe weakness
-Severe nervous system response - stiff muscles (rigidity), high fever sweating confusion fast uneven heartbeats shivering tremors feeling like you might pass out.
If any such symptoms occur while taking triazolam it is important to seek immediate medical attention. Always remember that this list does not include all possible side effects and others may occur.
What are the most common side effects for Ambien?
Ambien, a commonly prescribed medication for insomnia, can sometimes cause side effects:
- Dry mouth
- Drowsiness during the day
- Lightheadedness or dizziness
- Difficulty with coordination and balance
- Nausea and vomiting
- Upset stomach or constipation
- Changes in appetite
- Memory problems and confusion
- Anxiety or restlessness
-Unusual dreams
-Muscle pain.
It's important to note that Ambien should not be taken unless you are able to get a full night's sleep before you must be active again as it can affect your alertness and reflexes.
Are there any potential serious side effects for Ambien?
While Ambien is generally considered safe when used correctly, it's important to be aware that there can still be some potentially serious side effects. If you experience any of the following after taking Ambien, seek medical help immediately:
- Signs of an allergic reaction including hives; difficulty breathing; swelling in your face or throat
- Unusual thoughts, risk-taking behavior, decreased inhibitions or no fear of danger
- Anxiety and depression symptoms such as suicidal thoughts or feelings
- Hallucinations or confusion
- Aggressive and restless behavior
- Memory issues like amnesia (forgetfulness) about events that occurred while under the medication's influence
- Problems with speech or vision
- Chest pain, irregular heartbeats; severe dizziness and fainting.
It's also vital to note that discontinuing Ambien suddenly can lead to withdrawal symptoms. Always consult a healthcare professional before making changes to your prescribed regimen.
Contraindications for Triazolam and Ambien?
Both Triazolam and Ambien, along with most other sleep medications, may worsen symptoms of insomnia or create a dependency in some people. If you notice your insomnia worsening, or an increase in dependency on these drugs for sleep, please seek immediate medical attention.
Neither Triazolam nor Ambien should be taken if you are taking or have recently stopped taking certain antifungal treatments (such as ketoconazole), certain antibiotics (like erythromycin) or consuming grapefruit/grapefruit juice; they can significantly affect the metabolism of these substances leading to dangerously high concentrations. Always inform your physician about all other medications that you are currently taking; stopping such interacting medicines will require some time to clear from the system to prevent harmful interactions with Triazolam and Ambien.
How much do Triazolam and Ambien cost?
For the brand name versions of these drugs:
- The price of 30 tablets of Halcion (triazolam, 0.25 mg) averages around $120, which works out to approximately $4/day.
- The price for a similar quantity of Ambien (zolpidem, 10 mg) is about $190 on average, or roughly $6.30 per day.
Thus, if you are taking one tablet per night as typically prescribed for insomnia treatment, then brand-name Halcion is less expensive on a daily basis than Ambien. However, keep in mind that cost should not be your primary consideration when deciding which medication is right for you.
For the generic versions of triazolam and zolpidem:
- Triazolam (0.25 mg tablets) can be found in packs of 30 at an approximate cost ranging from $15 to $60 depending on location and pharmacy choice; this equates to daily costs between $.50 and $2.
- Zolpidem comes in packs starting from 5 up to more than a hundred pills (10 mg). The prices start as low as about $.50/day if buying larger quantities upfront but may go up to around $3/day for smaller packages or depending upon location/pharmacy choice.
Popularity of Triazolam and Ambien
Triazolam, available under brand names such as Halcion, was prescribed to approximately 400,000 people in the US in 2020. Triazolam is a short-acting benzodiazepine and is primarily used for the treatment of severe insomnia. It has been around longer than many of its counterparts but has seen a decline in use over recent years due to concerns about side effects and potential for dependency.
Zolpidem, including brand versions like Ambien and Ambien CR, was prescribed to nearly 10 million people in the USA during the same year. Zolpidem accounts for about one-third of all sleep aid prescriptions in the US. The prevalence of zolpidem as a sleep aid can be attributed largely due to its efficacy at inducing sedation with fewer side effects associated with traditional benzodiazepines like triazolam. However, it's important to note that both medications have risks if not taken as directed by your healthcare provider.
Conclusion
Both Triazolam and Ambien (also known as zolpidem) have a long-standing history of usage in patients with insomnia and are supported by numerous clinical studies demonstrating their effectiveness over placebo treatments. In some cases, the drugs may be used together under careful physician supervision due to potential interactions between them. Both medicines work on GABA receptors, but they bind to different subunits which results in somewhat differing effects.
Triazolam is primarily prescribed for short-term treatment of severe sleep-onset insomnia whereas Ambien is often considered for both sleep onset and sleep maintenance issues. Triazolam's shorter half-life makes it less likely to cause morning grogginess compared to Ambien.
Both drugs are available generically, offering substantial savings especially for out-of-pocket patients. The medications' effect should be immediate given their use case; however, people can build tolerance if these drugs are not used judiciously.
The side-effect profile for both drugs includes dizziness, daytime drowsiness or "hangover" feeling, memory problems or confusion particularly among older adults. Of particular note is that both substances carry a risk of dependency and withdrawal symptoms if stopped abruptly after prolonged use. Patients must carefully monitor themselves when using these medications and seek medical help immediately if they notice any unusual behavior changes or thoughts about self-harm.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Mintzer, M. Z., Frey, J. M., & Griffiths, R. R. (1998, November). Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure. Behavioural Pharmacology. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1097/00008877-199811000-00010
- Manfredi, R., & Kales, A. (1987, September). Clinical Neuropharmacology of Sleep Disorders. Seminars in Neurology. Georg Thieme Verlag KG.http://doi.org/10.1055/s-2008-1041429
- Vogel, G., Thurmond, A., Gibbons, P., Edwards, K., Sloan, K. B., & Sexton, K. (1975). The effect of triazolam on the sleep of insomniacs. Psychopharmacologia. Springer Science and Business Media LLC.http://doi.org/10.1007/bf00421308
- Johnson, M. W., Suess, P. E., & Griffiths, R. R. (2006, October 1). Ramelteon. Archives of General Psychiatry. American Medical Association (AMA).http://doi.org/10.1001/archpsyc.63.10.1149
- Kroboth, P. D., & Juhl, R. P. (1983, July). Triazolam (Halcion, the Upjohn Company). Drug Intelligence & Clinical Pharmacy. SAGE Publications.http://doi.org/10.1177/106002808301700701
- Uygun, D. S., Ye, Z., Zecharia, A. Y., Harding, E. C., Yu, X., Yustos, R., … Wisden, W. (2016, November 2). Bottom-Up versus Top-Down Induction of Sleep by Zolpidem Acting on Histaminergic and Neocortex Neurons. The Journal of Neuroscience. Society for Neuroscience.http://doi.org/10.1523/jneurosci.3714-15.2016
- Barkin, R. L. (2007, May). Zolpidem Extended-Release: A Single Insomnia Treatment Option for Sleep Induction and Sleep Maintenance Symptoms. American Journal of Therapeutics. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1097/mjt.0b013e31804c7292
- Sancar, F., Ericksen, S. S., Kucken, A. M., Teissére, J. A., & Czajkowski, C. (2006, September 29). Structural Determinants for High-Affinity Zolpidem Binding to GABA-A receptors. Molecular Pharmacology. American Society for Pharmacology & Experimental Therapeutics (ASPET).http://doi.org/10.1124/mol.106.029595
- Kanno, O., Sasaki, T., Watanabe, H., Takazawa, S., Nakagome, K., Nakajima, T., … Suzuki, M. (2000, August). Comparison of the effects of zolpidem and triazolam on nocturnal sleep and sleep latency in the morning: A cross-over study in healthy young volunteers. Progress in Neuro-Psychopharmacology and Biological Psychiatry. Elsevier BV.http://doi.org/10.1016/s0278-5846(00)00117-2
- Dehlin, O., Bj�rnson, G., B�rjesson, L., Abrahamsson, L., & Smith, R. B. (1983). Pharmacokinetics of triazolam in geriatric patients. European Journal of Clinical Pharmacology. Springer Science and Business Media LLC.http://doi.org/10.1007/bf00544022
- Lobo, B. L., & Greene, W. L. (1997, May). Zolpidem: Distinct from Triazolam?. Annals of Pharmacotherapy. SAGE Publications.http://doi.org/10.1177/106002809703100518